Glatiramer acetate (GA) therapy induces a focused, oligoclonal CD8+ T-cell repertoire in multiple sclerosis
- 30 November 2006
- journal article
- clinical trial
- Published by Elsevier BV in Journal of Neuroimmunology
- Vol. 180 (1-2), 159-171
- https://doi.org/10.1016/j.jneuroim.2006.07.015
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Immunomodulation by the copolymer glatiramer acetateJournal of Molecular Recognition, 2003
- Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cellsBlood, 2003
- Humoral and cellular immune responses to Copolymer 1 in multiple sclerosis patients treated with Copaxone®Journal of Neuroimmunology, 2001
- Specific Th2 cells accumulate in the central nervous system of mice protected against experimental autoimmune encephalomyelitis by copolymer 1Proceedings of the National Academy of Sciences, 2000
- Clonal Expansions of Cd8+ T Cells Dominate the T Cell Infiltrate in Active Multiple Sclerosis Lesions as Shown by Micromanipulation and Single Cell Polymerase Chain ReactionThe Journal of Experimental Medicine, 2000
- Bystander suppression of experimental autoimmune encephalomyelitis by T cell lines and clones of the Th2 type induced by copolymer 1Journal of Neuroimmunology, 1998
- Copolymer 1 induces T cells of the T helper type 2 that crossreact with myelin basic protein and suppress experimental autoimmune encephalomyelitisProceedings of the National Academy of Sciences, 1997
- Oligoclonality of CD8 + T cells in health and disease: Aging, infection, or immune regulation?Human Immunology, 1996
- Multiple sclerosis: Trial of a synthetic polypeptideAnnals of Neurology, 1982
- Effect of a synthetic polypeptide (Cop 1) on patients with multiple sclerosis and with acute disseminated encephalomyelitisJournal of the Neurological Sciences, 1977